Latest Health News

K2 Asset Management has appointed longtime executive Hollie Wight as CEO, signaling a strategic push towards sustained profitability and diversified revenue growth in 2025.

Magnis Energy Technologies reveals that its partners IM3NY LLC and Imperium3 New York Inc have entered Chapter 11 bankruptcy proceedings, raising questions about future operations and financial stability.

Foresta Group Holdings has raised $3.1 million through a convertible note and share placement, while securing exclusive technology licensing and key offtake agreements to propel its flagship New Zealand biomass project.

Singular Health has secured a pivotal MoU with Miami-based Provider Network Solutions and raised $3.7 million to propel its 3Dicom software towards a US commercial pilot, supported by the appointment of esteemed radiologist Dr. Ronny Low.

TrivarX has secured positive feedback from the FDA on its pivotal trial design for MEB-001, an AI-driven algorithm targeting major depressive episode screening via sleep study data. The company is advancing site collaborations to launch a large-scale US trial.

Anatara Lifesciences has been granted a key Australian patent for its GaRP gastrointestinal health product, reinforcing its intellectual property portfolio ahead of pivotal clinical trial results expected in March 2025.

PARKD Ltd reports substantial structural completions on flagship projects and positive operating cash flow in Q2 FY25, setting the stage for licensing negotiations with Fielders.

Cooper Metals reports promising exploration progress at its Mt Isa East copper-gold project and high-grade gold assays at the Gooroo project, while maintaining a solid cash reserve of $2.1 million.

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

Hydrix Limited reports back-to-back profitable quarters driven by strong margins and cost efficiencies, underpinned by a robust $40 million sales opportunity pipeline in cardiac and medtech sectors.

Killi Resources reports compelling drill results from its Kaa gold-copper prospect in Queensland, confirming a large mineralised system and maintaining a strong cash position of $2.03 million to fund ongoing exploration.

De.mem Limited has delivered its second highest quarterly cash receipts ever alongside positive operating cash flow for the December 2024 quarter, marking a milestone full-year cash flow turnaround and setting the stage for continued growth in 2025.